Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research | 2018 |
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research | 2018 |